Research Article

Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity

Volume: 11 Number: 04 December 15, 2021
  • Nosakhare Lawrence Idemudıa *
  • Helen Oroboghae Ogefere
  • Richard Omoregie
EN

Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity

Abstract

Objectives: Objective: The role of some basic immune-inflammatory markers in malaria is yet to be investigated in our locality. This study was conducted to determine the relationship between some predictive immune-inflammatory markers and malaria among malaria-infected persons in Benin City, Nigeria. Methods: EDTA blood specimens were collected from 400 malaria patients attending outpatient clinics and in the wards of major hospitals in Benin City. The blood samples were used for malaria parasite density determination and complete blood count analysis of some basic inflammatory markers such as Neutrophil/Lymphocyte Ratio (NLR), Monocyte/Neutrophil Ratio (MNR), Platelet/Lymphocyte Ratio (PLR), Monocyte/Lymphocyte Ratio (MLR) and Systemic Immune-inflammatory Index (SII) were calculated from the obtained parameter of the Full Blood Count and the data analyzed. Results: Levels of parasitemia amongst malaria patients were not significantly affected by all the demographic characteristics profiled in this study. Eosinophils percentage count was significantly higher in individuals with high parasitemia (p=0.0121). Of all the Socio-demographic factors analyzed in this study, only living arrangements affected the MPV of malaria patients, showing that MPV was significantly higher in patients living in one room (p=0.0407). Immune inflammatory markers correlated significantly and positively with malaria MLR (r=0.322, p<0.0001), MNR (r=0.241, p<0.0001), NLR (r=0.122, p=0.015), SII (r=0.115, p=0.022) and PLR (r=0.109, p=0.030). Conclusion: NLR, MNR, MLR, PLR, and SII are positively associated with malaria parasitemia. Therefore, these inflammatory immune markers can be used as a cost-effective way of assessing malaria severity as well as for malaria prognosis. J Microbiol Infect Dis 2021; 11(4):201-208.

Keywords

References

  1. 1. Gowda DC, Wu X. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria. Front. Immunol. 2018; 9:3006. doi: 10.3389/fimmu.2018.03006 2. WHO. World malaria report 2020. World Health Organisation, 2020; Geneva, Switzerland.
  2. 3. Centre for Disease Control and Prevention (CDC). CDC’s Malaria Program. 2020; U.S. Department of Health & Human Services
  3. 4. Laishram DD, Sutton PL, Nanda N, et al. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J 2012;11:29. https://doi.org/10.1186/1475-2875-11-29
  4. 5. Deroost K, Pham TT, Opdenakker G, Van den Steen PE. The immunological balance between host and parasite in malaria. FEMS microbiology reviews 2016; 40(2), 208-257.
  5. 6. Horne BD, Anderson JL, John JM. Which white blood cell subtypes predict increased cardiovascular risk? J. Am. Coll. Cardiol. 2005; 45:1638–1643.
  6. 7. Kassa D, Petros B, Mesele T, Hailu E, Wolday D. Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia. Clin Vaccine Immunol. 2006; 13:376–9.
  7. 8. Berens-Riha N, Kroidl I, Schunk M, et al. evidence for signifcant infuence of host immunity on changes in differential blood count during malaria. Malar J. 2014;13:155. https://doi.org/10.1186/1475-2875-13-155
  8. 9. Olliaro P, Djimde A, Dorsey G, et al. Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg 2011;85: 619–625.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Nosakhare Lawrence Idemudıa * This is me
Nigeria

Helen Oroboghae Ogefere This is me
Nigeria

Richard Omoregie This is me
Nigeria

Publication Date

December 15, 2021

Submission Date

March 15, 2021

Acceptance Date

November 23, 2021

Published in Issue

Year 2021 Volume: 11 Number: 04

APA
Idemudıa, N. L., Ogefere, H. O., & Omoregie, R. (2021). Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity. Journal of Microbiology and Infectious Diseases, 11(04), 201-208. https://doi.org/10.5799/jmid.1036763
AMA
1.Idemudıa NL, Ogefere HO, Omoregie R. Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity. J Microbil Infect Dis. 2021;11(04):201-208. doi:10.5799/jmid.1036763
Chicago
Idemudıa, Nosakhare Lawrence, Helen Oroboghae Ogefere, and Richard Omoregie. 2021. “Use of Some Surrogate Markers of Inflammation As Predictor of Malaria Severity”. Journal of Microbiology and Infectious Diseases 11 (04): 201-8. https://doi.org/10.5799/jmid.1036763.
EndNote
Idemudıa NL, Ogefere HO, Omoregie R (December 1, 2021) Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity. Journal of Microbiology and Infectious Diseases 11 04 201–208.
IEEE
[1]N. L. Idemudıa, H. O. Ogefere, and R. Omoregie, “Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity”, J Microbil Infect Dis, vol. 11, no. 04, pp. 201–208, Dec. 2021, doi: 10.5799/jmid.1036763.
ISNAD
Idemudıa, Nosakhare Lawrence - Ogefere, Helen Oroboghae - Omoregie, Richard. “Use of Some Surrogate Markers of Inflammation As Predictor of Malaria Severity”. Journal of Microbiology and Infectious Diseases 11/04 (December 1, 2021): 201-208. https://doi.org/10.5799/jmid.1036763.
JAMA
1.Idemudıa NL, Ogefere HO, Omoregie R. Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity. J Microbil Infect Dis. 2021;11:201–208.
MLA
Idemudıa, Nosakhare Lawrence, et al. “Use of Some Surrogate Markers of Inflammation As Predictor of Malaria Severity”. Journal of Microbiology and Infectious Diseases, vol. 11, no. 04, Dec. 2021, pp. 201-8, doi:10.5799/jmid.1036763.
Vancouver
1.Nosakhare Lawrence Idemudıa, Helen Oroboghae Ogefere, Richard Omoregie. Use of Some Surrogate Markers of Inflammation as Predictor of Malaria Severity. J Microbil Infect Dis. 2021 Dec. 1;11(04):201-8. doi:10.5799/jmid.1036763